Skip to main content
. 2020 Sep 11;31(11):2653–2666. doi: 10.1681/ASN.2020040411

Table 5.

Adverse events by treatment groups

Outcome Variable n (%) P Value
Placebo (n=140) Lanthanum (n=138)
Any SAE 66 (47) 61 (44) 0.62
 Death from any cause 8 (6) 2 (1) 0.10a
 Life-threatening event 0 4 (3) 0.06a
 Initial or prolonged inpatient hospitalization 64 (46) 58 (42) 0.54
 Persistent/significant disability 1 (<1) 2 (1) 0.62a
 Important medical event 7 (5) 8 (6) 0.77
Any adverse drug reaction 16 (11) 18 (13) 0.68
 Gastrointestinal eventb 10 (7) 8 (6) 0.65
 Nausea/vomiting 4 (3) 6 (4) 0.54a
 Other event 6 (4) 4 (3) 0.75a

SAE, serious adverse event.

a

Fisher exact test.

b

Includes diarrhea, constipation, gastroesophageal reflux.